LENSAR Reports 18% Revenue Growth and Net Income Turnaround in Q2 2026

LENSAR, Inc. reported a significant improvement in its financial performance for the second quarter of 2026, with total revenue reaching $16.5 million, an 18% increase from $13.9 million in the same period last year. The company's net income for the quarter was $3.5 million, a notable turnaround from a net loss of $1.8 million in the prior year. This positive shift was primarily attributed to a decrease in the change in fair value of warrant liabilities, which improved by $1.2 million compared to the previous year. For the first half of 2026, LENSAR's revenue also increased by 7% to $29.9 million, up from $28.1 million in the first half of 2025, with net income of $39.9 million compared to a net loss of $29.1 million.

The company experienced growth across its product lines, with product revenue increasing by 20% to $13.0 million for the three months ended June 30, 2026, driven by higher procedure volumes. Service revenue also rose by 22% to $1.7 million, reflecting an increase in system placements. However, lease revenue saw a slight increase of 8% to $1.8 million. The total installed base of LENSAR systems reached approximately 445 units as of June 30, 2026, indicating a solid market presence.

Strategically, LENSAR has focused on expanding its commercial organization, which included approximately 70 sales professionals as of the end of the second quarter. The company has also launched its next-generation ALLY Robotic Cataract Laser System, which has received regulatory clearances in multiple regions, including the U.S., EU, India, Taiwan, and South Korea. The company is actively pursuing additional certifications to enhance its market reach. However, LENSAR noted that global economic conditions, including inflation and supply chain disruptions, could impact its operations and pricing strategies.

In terms of operational metrics, LENSAR's cash and cash equivalents stood at $13.6 million as of June 30, 2026, with a significant accumulated deficit of $137.7 million. The company has entered into a $10 million asset-based revolving credit facility to support its liquidity needs, which will be crucial as it continues to navigate the challenges posed by macroeconomic factors. Looking ahead, LENSAR anticipates an increase in annual revenue and selling, general, and administrative expenses as it ramps up its efforts to commercialize the ALLY System and expand its market presence. The company remains cautious about its future profitability, given the uncertainties in the regulatory landscape and market conditions.